Literature DB >> 2892567

Peptic ulceration.

D G Weir1.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 2892567      PMCID: PMC2544911     

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  19 in total

1.  Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists.

Authors:  G N Tytgat; C B Lamers; W Hameeteman; J M Jansen; J A Wilson
Journal:  Aliment Pharmacol Ther       Date:  1987-02       Impact factor: 8.171

2.  Relapse of duodenal ulcer: does it matter which drug is used in initial treatment?

Authors:  J P Miller; E B Faragher
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

3.  [Comparative efficacy of ranitidine and cimetidine in the short-term treatment of duodenal ulcer (results of an international controlled trial)].

Authors:  C Laverdant
Journal:  Gastroenterol Clin Biol       Date:  1983-05

Review 4.  Emerging strategies in ulcer therapy: pumps and receptors.

Authors:  T Berglindh; G Sachs
Journal:  Scand J Gastroenterol Suppl       Date:  1985

5.  Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?

Authors:  P Bauerfeind; T Cilluffo; C J Fimmel; C Emde; C von Ritter; W Kohler; R Gugler; T Gasser; A L Blum
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

6.  The fate of asymptomatic recurrences of duodenal ulcer.

Authors:  E J Boyd; J A Wilson; K G Wormsley
Journal:  Scand J Gastroenterol       Date:  1984-09       Impact factor: 2.423

Review 7.  Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546

8.  Impaired proximal duodenal mucosal bicarbonate secretion in patients with duodenal ulcer.

Authors:  J I Isenberg; J A Selling; D L Hogan; M A Koss
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

9.  Comparison of ranitidine and high-dose antacid in the treatment of prepyloric or duodenal ulcer. A double-blind controlled trial.

Authors:  K Lauritsen; P Bytzer; J Hansen; C Bekker; J Rask-Madsen
Journal:  Scand J Gastroenterol       Date:  1985-01       Impact factor: 2.423

10.  Model of medical treatment for duodenal ulcer.

Authors:  R E Pounder
Journal:  Lancet       Date:  1981-01-03       Impact factor: 79.321

View more
  1 in total

1.  Antimuscarinic and anticholinesterase activity of cimetidine and ranitidine: clinically significant?

Authors:  M C Gwee; L S Cheah
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.